PHKA2 Gene Glycogen Storage Disease Type 9A Genetic Test
Test Name:
PHKA2 Gene Glycogen storage disease type 9A Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for PHKA2 Gene Glycogen storage disease type 9A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 9A.
Test Details:
The PHKA2 gene is responsible for producing a protein called phosphorylase kinase alpha 2 subunit, which plays a crucial role in the breakdown of glycogen into glucose in the body. Mutations in the PHKA2 gene can lead to a rare genetic disorder called glycogen storage disease type 9A (GSD9A). GSD9A is an autosomal recessive disorder, meaning that individuals need to inherit two copies of the mutated PHKA2 gene (one from each parent) to develop the disease. This condition affects the liver and muscles, impairing the ability to break down glycogen into glucose. As a result, affected individuals may experience symptoms such as muscle weakness, fatigue, low blood sugar levels, and an enlarged liver.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, including the PHKA2 gene, to identify mutations or variants that may be associated with GSD9A. This type of testing can help diagnose the condition and provide information about the specific genetic changes involved.
If you suspect that you or someone you know may have GSD9A, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate medical advice and support.
Test Name | PHKA2 Gene Glycogen storage disease type 9A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PHKA2 Gene Glycogen storage disease type 9A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 9A |
Test Details |
The PHKA2 gene is responsible for producing a protein called phosphorylase kinase alpha 2 subunit, which plays a crucial role in the breakdown of glycogen into glucose in the body. Mutations in the PHKA2 gene can lead to a rare genetic disorder called glycogen storage disease type 9A (GSD9A). GSD9A is an autosomal recessive disorder, meaning that individuals need to inherit two copies of the mutated PHKA2 gene (one from each parent) to develop the disease. This condition affects the liver and muscles, impairing the ability to break down glycogen into glucose. As a result, affected individuals may experience symptoms such as muscle weakness, fatigue, low blood sugar levels, and an enlarged liver. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, including the PHKA2 gene, to identify mutations or variants that may be associated with GSD9A. This type of testing can help diagnose the condition and provide information about the specific genetic changes involved. If you suspect that you or someone you know may have GSD9A, it is recommended to consult with a healthcare professional or a genetic counselor who can guide you through the testing process and provide appropriate medical advice and support. |